The 5 constituents in ‘s Canadian Cannabis LPs Index were down 1.7% last week after having gone up 12,5% the previous week and down 3.9% the week before that. The volatility continues!Below are the performances of the constituents in the Index last week, in descending order, and for the previous week along with each stock’s forward-price-to-sales ratio (PSR), and enterprise value-to-earnings before interest, taxes, depreciation and amortization (EV/EBITDA) ratio to provide a comparative valuation of each, where applicable, plus the latest news on each company. A definition of each ratio is at the end of the article.Canadian Cannabis LPs Index
- Forward Price-to-Sales Ratio (PSR): 9.1 (High – above the sector mean of 3.4)
- EV/EBITDA ratio: Negative
- Latest News: Cronos Q3 Financial Results Are Impressive
- Forward Price-to-Sales Ratio (PSR): 1.0
- EV/EBITDA ratio: 9.9
- Latest News: Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool
- Forward Price-to-Sales Ratio (PSR): 1.1
- EV/EBITDA ratio: 24.5 (High – sector mean is 12.4)
- Latest News: Aurora Cannabis’ Q2 Net Income Was Positive For The First Time
- Forward Price-to-Sales Ratio (PSR): 1.5
- EV/EBITDA ratio: 19.5 (High – sector mean is 12.4)
- Latest News: Tilray Launches ‘Get Blitzen’d’ Holiday Campaign and New Limited-Edition Products Across Canada
- Forward Price-to-Sales Ratio (PSR): 1.8
- EV/EBITDA ratio: Negative
- Latest News: Canopy Growth Q2 Financials Show Improvement
LP Stock Performance SummaryIndex Average: down 1.7% last week, up 12.5% the previous week and now down 47.3% YTD.Understanding Valuation Metrics To evaluate these companies, investors often look at these key ratios, among others:
These metrics are essential for investors to understand the financial health and potential of companies in comparison to each other within the Health Care/Pharmaceuticals sector.More By This Author:
